Drive Capital

Drive Capital is a Columbus, Ohio-based venture firm founded in 2012 with a clear thesis: build a generational venture franchise outside Silicon Valley by backing high-growth companies in the Midwest and across the U.S. interior. The firm has scaled significantly since launch and is now one of the largest non-coastal venture managers, with a track record across software, healthcare, and consumer.

In healthcare, Drive’s thesis covers digital health, health IT, and AI/ML in healthcare, with an emphasis on software and data platforms that can scale across health systems, payers, and provider networks. The firm is comfortable with both consumer-facing health bets and enterprise software targeting healthcare buyers, and AI is increasingly central to how partners evaluate competitive moats in the category. Drive’s broader portfolio brings cross-industry insights into how data and AI are reshaping operating models, which informs its healthcare bets.

The firm invests at Seed, Series A, and Series B with check sizes of $5M to $25M, and it has the capital base to follow on aggressively into companies that hit early milestones. Geographic focus is the United States, with a deliberate emphasis on companies based outside coastal venture hubs, though the firm will back exceptional founders wherever they are. Founders should expect Drive to lead or co-lead rounds, take board seats, and participate meaningfully in subsequent rounds.

The team is partner-led with backgrounds spanning operating roles at major technology companies, prior venture investing, and finance. Drive’s investment process is conviction-driven and oriented toward backing ambitious founders who are building for scale. Diligence is rigorous on market sizing, unit economics, and team, and decisions typically move through a focused partnership process without unnecessary delay.

Drive’s working style is hands-on and growth-oriented. The firm is known for engaging substantively on go-to-market, hiring, and follow-on financing strategy, and it has built a network of operating advisors who can support portfolio companies on functional questions ranging from sales leadership to data infrastructure. For healthcare founders specifically, Drive brings access to relationships across Midwest health systems, payers, and academic medical centers, which can accelerate early commercial validation. The firm is comfortable with the longer commercial timelines typical of healthcare buyers but expects clear evidence of progress at each stage. Board engagement is formal and rigorous post-Series A, with quarterly cadences and active between-meeting collaboration on strategic questions. Drive will not be the right partner for founders looking for a passive capital relationship; the firm engages deeply with conviction-led bets. For ambitious healthcare software and AI founders looking for a well-capitalized partner with cross-sector pattern recognition and a network that extends well beyond traditional healthcare investors, Drive Capital is a credible option, particularly for companies whose growth trajectory matches the firm’s scale and time horizon.